| Ticker Details |
|
PharmaCyte Biotech, Inc.
|
| IPO Date: |
December 5, 2003 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.72M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.07 | 3.52%
|
| Avg Daily Range (30 D): |
$0.02 | 3.88%
|
| Avg Daily Range (90 D): |
$0.03 | 4.14%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.62M |
| Avg Daily Volume (30 D): |
.09M |
| Avg Daily Volume (90 D): |
.14M |
| Trade Size |
| Avg Trade Size (Sh.): |
307 |
| Avg Trade Size (Sh.) (30 D): |
449 |
| Avg Trade Size (Sh.) (90 D): |
519 |
| Institutional Trades |
| Total Institutional Trades: |
16 |
| Avg Institutional Trade: |
$1.4M |
| Avg Institutional Trade (30 D): |
$1.07M |
| Avg Institutional Trade (90 D): |
$1.07M |
| Avg Institutional Trade Volume: |
.37M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.52M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
209.41K |
|
|
| Financials |
| |
TTM |
Q4 2026 |
FY 2026 |
|
Basic EPS
|
$-2.77
|
|
$-2.77
|
|
Diluted EPS
|
$-2.77
|
|
$-2.77
|
|
Revenue
|
$M
|
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-19.42M
|
|
$-19.42M
|
|
Operating Income / Loss
|
$-6.85M
|
|
$-6.85M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$3.43M
|
|
$3.43M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 12, 2021
|
1:1500
|
|
Dec 08, 2003
|
3:1
|
|
|
|